Biomarkers of Pathological Response on Neo-Adjuvant Chemo-Immunotherapy Treatment for Resectable Stage IIIA NSCLC Patients

dc.contributor.authorLaza-Briviesca, R.
dc.contributor.authorCruz-Bermudez, A.
dc.contributor.authorCasarrubios, M.
dc.contributor.authorNadal, E.
dc.contributor.authorInsa, A.
dc.contributor.authorGarcia Campelo, R.
dc.contributor.authorDe Dios Alvarez, N.
dc.contributor.authorDomine, M.
dc.contributor.authorMajem, M.
dc.contributor.authorRodriguez-Abreu, D.
dc.contributor.authorCalvo De Juan, V.
dc.contributor.authorMartinez-Marti, A.
dc.contributor.authorDe Castro Carpeno, J.
dc.contributor.authorCobo, M.
dc.contributor.authorLopez-Vivanco, G.
dc.contributor.authorDel Barco, E.
dc.contributor.authorBernabe, R.
dc.contributor.authorVinolas, N.
dc.contributor.authorBarneto, I.
dc.contributor.authorViteri, S.
dc.contributor.authorMassuti, B.
dc.contributor.authorProvencio, M.
dc.contributor.authoraffiliation[Laza-Briviesca, R.] Hosp Univ Puerta de Hierro Majadahonda, Inst Invest Sanitaria Puerta de Hierro Majadahond, Serv Oncol Med, Madrid, Spain
dc.contributor.authoraffiliation[Cruz-Bermudez, A.] Hosp Univ Puerta de Hierro Majadahonda, Inst Invest Sanitaria Puerta de Hierro Majadahond, Serv Oncol Med, Madrid, Spain
dc.contributor.authoraffiliation[Casarrubios, M.] Hosp Univ Puerta de Hierro Majadahonda, Inst Invest Sanitaria Puerta de Hierro Majadahond, Serv Oncol Med, Madrid, Spain
dc.contributor.authoraffiliation[Calvo De Juan, V.] Hosp Univ Puerta de Hierro Majadahonda, Inst Invest Sanitaria Puerta de Hierro Majadahond, Serv Oncol Med, Madrid, Spain
dc.contributor.authoraffiliation[Provencio, M.] Hosp Univ Puerta de Hierro Majadahonda, Inst Invest Sanitaria Puerta de Hierro Majadahond, Serv Oncol Med, Madrid, Spain
dc.contributor.authoraffiliation[Nadal, E.] Inst Catala Oncol, Med Oncol, Barcelona, Spain
dc.contributor.authoraffiliation[Insa, A.] Hosp Clin Univ, Clin Fdn Incliva, Valencia, Spain
dc.contributor.authoraffiliation[Garcia Campelo, R.] Hosp Univ A Coruna, La Coruna, Spain
dc.contributor.authoraffiliation[De Dios Alvarez, N.] Hosp Univ Vigo, Pontevedra, Spain
dc.contributor.authoraffiliation[Domine, M.] Hosp Fdn Jimenez Iis Fjd, Madrid, Spain
dc.contributor.authoraffiliation[Majem, M.] Hosp La Santa Creu & St Pau, Barcelona, Spain
dc.contributor.authoraffiliation[Rodriguez-Abreu, D.] Hosp Insular Gran Canaria, Las Palmas Gran Canaria, Spain
dc.contributor.authoraffiliation[Martinez-Marti, A.] Vall Dhebron Univ Hosp, Barcelona, Spain
dc.contributor.authoraffiliation[Martinez-Marti, A.] Inst Oncol Vhio, Barcelona, Spain
dc.contributor.authoraffiliation[De Castro Carpeno, J.] Hosp Univ La Paz, Madrid, Spain
dc.contributor.authoraffiliation[Cobo, M.] Univ Hosp Reg Malaga, Malaga, Spain
dc.contributor.authoraffiliation[Lopez-Vivanco, G.] Hosp Univ Cruces, Baracaldo, Spain
dc.contributor.authoraffiliation[Del Barco, E.] Hosp Univ Salamanca, Salamanca, Spain
dc.contributor.authoraffiliation[Bernabe, R.] Hosp Univ Virgen Del Rocio, Seville, Spain
dc.contributor.authoraffiliation[Vinolas, N.] Clin Hosp, Oncol, Barcelona, Spain
dc.contributor.authoraffiliation[Barneto, I.] Hosp Univ Reina Sofia, Cordoba, Spain
dc.contributor.authoraffiliation[Viteri, S.] Hosp Univ Quiron Dexeus, Inst Oncol Dr Rosell, Grp Quironsalud, Barcelona, Spain
dc.contributor.authoraffiliation[Massuti, B.] Hosp Gen Alicante, Alicante, Spain
dc.date.accessioned2025-01-07T13:39:22Z
dc.date.available2025-01-07T13:39:22Z
dc.date.issued2019-10-01
dc.identifier.doi10.1016/j.jtho.2019.08.1515
dc.identifier.essn1556-1380
dc.identifier.issn1556-0864
dc.identifier.unpaywallURLhttp://www.jto.org/article/S1556086419321987/pdf
dc.identifier.urihttps://hdl.handle.net/10668/25728
dc.identifier.wosID492162203430
dc.issue.number10
dc.issue.numberS
dc.journal.titleJournal of thoracic oncology
dc.journal.titleabbreviationJ. thorac. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Reina Sofía
dc.organizationSAS - Hospital Universitario Regional de Málaga
dc.organizationSAS - Hospital Universitario Virgen del Rocío
dc.page.numberS711-S711
dc.publisherElsevier science inc
dc.rights.accessRightsopen access
dc.subjectstage IIIA NSCLC
dc.subjectbiomarkers
dc.subjectneo-adjuvant chemo-immunotherapy
dc.titleBiomarkers of Pathological Response on Neo-Adjuvant Chemo-Immunotherapy Treatment for Resectable Stage IIIA NSCLC Patients
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number14
dc.wostypeMeeting Abstract

Files